Boston sells stake in Cyberonics for $48.6m
This article was originally published in Clinica
Executive Summary
Last week ended on a sour note for embattled neuromodulation company Cyberonics when its largest shareholder, Boston Scientific, disposed of its stake in the company on Friday (October 5).